Abstract:Poor pharmacokinetics is one of the reasons for the withdrawal of drug candidates from clinical trials. There is an urgent need for investigating in vitro ADME (absorption, distribution, metabolism and excretion) properties and recognising unsuitable drug candidates as early as possible in the drug development process. Current throughput of in vitro ADME profiling is insufficient because effective new synthesis techniques, such as drug design in silico and combinatorial synthesis, have vastly increased the number of drug candidates. Assay technologies for larger sets of compounds than are currently feasible are critically needed. The first part of this work focused on the evaluation of cocktail strategy in studies of drug permeability and metabolic stability. N-in-one liquid chromatography-tandem mass spectrometry (LC/MS/MS) methods were developed and validated for the multiple component analysis of samples in cocktail experiments. Together, cocktail dosing and LC/MS/MS were found to form an effective tool for increasing throughput. First, cocktail dosing, i.e. the use of a mixture of many test compounds, was applied in permeability experiments with Caco-2 cell culture, which is a widely used in vitro model for small intestinal absorption. A cocktail of 7-10 reference compounds was successfully evaluated for standardization and routine testing of the performance of Caco-2 cell cultures. Secondly, cocktail strategy was used in metabolic stability studies of drugs with UGT isoenzymes, which are one of the most important phase II drug metabolizing enzymes. The study confirmed that the determination of intrinsic clearance (Clint) as a cocktail of seven substrates is possible. The LC/MS/MS methods that were developed were fast and reliable for the quantitative analysis of a heterogenous set of drugs from Caco-2 permeability experiments and the set of glucuronides from in vitro stability experiments. The performance of a new ionization technique, atmospheric pressure photoionization (APPI), was evaluated through comparison with electrospray ionization (ESI), where both techniques were used for the analysis of Caco-2 samples. Like ESI, also APPI proved to be a reliable technique for the analysis of Caco-2 samples and even more flexible than ESI because of the wider dynamic linear range. The second part of the experimental study focused on metabolite profiling. Different mass spectrometric instruments and commercially available software tools were investigated for profiling metabolites in urine and hepatocyte samples. All the instruments tested (triple quadrupole, quadrupole time-of-flight, ion trap) exhibited some good and some bad features in searching for and identifying of expected and non-expected metabolites. Although, current profiling software is helpful, it is still insufficient. Thus a time-consuming largely manual approach is still required for metabolite profiling from complex biological matrices.

Application of LC/APCI/MS in Studying Metabolism of Drugs with Small Molecular Weight

Study on Urinary Metabonmics Using Rapid Resolution Liquid Chromatography Tandem Mass Spectrometry

Simultaneous Determination of 11 Illicit Drugs and Metabolites in Wastewater by UPLC-MS/MS.

Elucidating important factors and corresponding method optimization for sensitive detection of small peptide drugs in human urine by solid‐phase extraction and UPLC‐HRMS: The influence of MS scan modes, protein precipitants, and ammonium formate

Application of High-Performance Liquid Chromatography-Mass Spectrometry to Detection of Diuretics in Human Urine

On-site Testing of Multiple Drugs of Abuse in Urine by a Miniature Dual-Lit Mass Spectrometer.

Simutaneous Determination of Lactulose, Mannitol and Lactose in Urine with Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method

Doping Control Analysis of Small Peptides in Human Urine Using LC-HRMS with Parallel Reaction Monitoring Mode: Screening and Confirmation.

Analytical strategies for identifying drug metabolites

Simultaneous Quantitation of Paracetamol, Caffeine, Pseudoephedrine, Chlorpheniramine and Cloperastine in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Target-based metabolomics for fast and sensitive quantification of eight small molecules in human urine using HPLC-DAD and chemometrics tools resolving of highly overlapping peaks

Simultaneous quantitation of metformin and dapagliflozin in human plasma by LC-MS/MS: Application to a pharmacokinetic study

Rapid LC–MS assay for targeted metabolite quantification by serial injection into isocratic gradients

Simultaneous Determination of Major Phytocannabinoids, Their Main Metabolites, and Common Synthetic Cannabinoids in Urine Samples by Lc-Ms/Ms

Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.

Simultaneous analysis of antihyperglycemic small molecule drugs and peptide drugs by means of dual liquid chromatography high-resolution mass spectrometry

Liquid Chromatography-Mass Spectrometry in Studies of Drug Metabolism and Permeability

Simultaneous Quantification Of 38 Psychotropic Drugs And Relevant Metabolites In Blood Using Lc-Ms-Ms

Development of an analytical method to detect simultaneously 219 new psychoactive substances and 65 other substances in urine specimens using LC-QqQ MS/MS with CriticalPairFinder and TransitionFinder

Rapid and sensitive screening and selective quantification of antibiotics in human urine by two-dimensional ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

Determination of Clopidogrel and Its Metabolites in Plasma by LC-MS/MS and Its Application in the Pharmacokinetics Study in Mice